FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:1611-1612 May 29, 1997 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Chronic fibrotic liver disease accounts for virtually all nonpulmonary causes of mortality in patients with cystic fibrosis. Therefore, along with lung disease and nutritional status, liver fibrosis is an important predictor of the outcome of cystic fibrosis.¹ Until now, histologic staging of fibrosis has been the only method for assessing liver fibrosis. Noninvasive markers for diagnosis and follow-up of fibrotic liver disease are urgently needed, and in children these markers must be unaffected by growth velocity.² Circulating collagen VI resulting from collagen degradation³ has been found to be elevated in adults with fibrosis and cirrhosis of the . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Beljaars, L., Molema, G., Schuppan, D., Geerts, A., De Bleser, P. J., Weert, B., Meijer, D. K. F., Poelstra, K. (2000). Successful Targeting to Rat Hepatic Stellate Cells Using Albumin Modified with Cyclic Peptides That Recognize the Collagen Type VI Receptor. J. Biol. Chem. 275: 12743-12751 [Abstract] [Full Text]  
• Ruhl, M., Sahin, E., Johannsen, M., Somasundaram, R., Manski, D., Riecken, E. O., Schuppan, D. (1999). Soluble Collagen VI Drives Serum-starved Fibroblasts through S Phase and Prevents Apoptosis via Down-regulation of Bax. J. Biol. Chem. 274: 34361-34368 [Abstract] [Full Text]  
• Wilschanski, M., Rivlin, J., Cohen, S., Augarten, A., Blau, H., Aviram, M., Bentur, L., Springer, C., Vila, Y., Branski, D., Kerem, B., Kerem, E. (1999). Clinical and Genetic Risk Factors for Cystic Fibrosis-related Liver Disease. Pediatrics 103: 52-57 [Abstract] [Full Text]